BMI1 and neoplasm: Furthermore, a recently developed synthetic small molecule compound called QW24 exhibits strong anti-tumor activity by inhibiting Bmi-1 and stopping CSCs from self-renewing in vivo with no discernible toxicity, indicating that QW24 may one day be employed as a successful therapeutic agent for the treatment of colorectal cancer in clinical settings [35].